Mandate

Vinge advises Brummer & Partners in connection with its investment in Saltside Technologies AB

January 29, 2015

Vinge advises Frontier PE (Cayman) L.P., a fond managed by Brummer & Partners, in connection with its investment in Saltside Technologies AB together with Kinnevik and Hillhouse Capital. Saltside Technologies AB operates the leading online horizontal classifieds platforms in three frontier markets through Bikroy (Bangladesh), Ikman (Sri Lanka) and Tonaton (Ghana). All three platforms are market leaders in terms of user base, engagement and monetization. The headquarters are located in Dubai and the group has over 200 employees to date. Frontier PE (Cayman) L.P. is a private equity fund based in Bangladesh and managed by Brummer & Partners, a leading European manager of hedge funds. Brummer & Partners manages 125 billion SEK on behalf of private persons, corporations and institutional investors.

The Vinge team advising Frontier PE (Cayman) L.P. includes partners Christina Kokko and Johan Larsson together with associates Maria Dahlin, Karin Virding and Nicklas Thorgerzon.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025